TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 3888464

Group type: EXPERIMENTAL
Intervention: Taurine
Number of subjects: 14

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 14
Study: 30086140

Group type: EXPERIMENTAL
Intervention: Subtitles displayed concurrently with the speech
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Subtitles displayed after speech offset
Number of subjects: 0

Group type: COMPARATOR
Intervention: No subtitles displayed
Number of subjects: 0
Study: 26706665

Group type: EXPERIMENTAL
Intervention: Metformin (1500 mg/day)
Number of subjects: 333

Group type: EXPERIMENTAL
Intervention: Weight loss intervention (personalized, telephone-based program targeting 7% weight loss)
Number of subjects: 333

Group type: EXPERIMENTAL
Intervention: Weight loss intervention and Metformin
Number of subjects: 333

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 333
Study: 24886455

Group type: EXPERIMENTAL
Intervention: Mechanical traction (12 treatments over six consecutive weeks)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Care as usual
Number of subjects: 0
Study: 22243632

Group type: EXPERIMENTAL
Intervention: High-saturated fat (HSF) diet
Number of subjects: 88

Group type: EXPERIMENTAL
Intervention: High-saturated fat (HSF-DHA) diet
Number of subjects: 88
Study: 19582583

Group type: EXPERIMENTAL
Intervention: Ambiguous nouns (multiple meanings)
Number of subjects: 0
Study: 17508190

Group type: EXPERIMENTAL
Intervention: 7.5 mg hyperbaric 0.5% levobupivacaine
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: 10 mg hyperbaric 0.5% levobupivacaine
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: 12.5 mg hyperbaric 0.5% levobupivacaine
Number of subjects: 30

Group type: COMPARATOR
Intervention: 10 mg vs 12.5 mg hyperbaric 0.5% levobupivacaine
Number of subjects: 30
Study: 16371677

Group type: EXPERIMENTAL
Intervention: Schoolwide intervention that incorporated universal and targeted treatment
Number of subjects: 4

Group type: EXPERIMENTAL
Intervention: Targeted-school intervention delivered to individual students
Number of subjects: 4

Group type: EXPERIMENTAL
Intervention: Targeted-home intervention delivered in home and regular classroom settings
Number of subjects: 4

Group type: COMPARATOR
Intervention: Control condition that did not receive a designated intervention
Number of subjects: 4
Study: 12215004

Group type: EXPERIMENTAL
Intervention: Group session with a Filipino health educator discussing health benefits of exercise
Number of subjects: 530

Group type: COMPARATOR
Intervention: Group session with a Filipino health educator discussing breast and cervical cancer screening
Number of subjects: 530
Study: 10205469

Group type: EXPERIMENTAL
Intervention: Neonatal Resuscitation Program (NRP)
Number of subjects: 102
Study: 8555131

Group type: EXPERIMENTAL
Intervention: One single pre‐operative dose of metronidazole (10 mg/kg)
Number of subjects: 544

Group type: EXPERIMENTAL
Intervention: Both metronidazole (20 mg/kg) and cefuroxime (50 mg/kg) in a single preoperative dose
Number of subjects: 544

Group type: COMPARATOR
Intervention: No antibiotics
Number of subjects: 544

Group type: EXPERIMENTAL
Intervention: Preoperative antibiotics (metronidazole and cefuroxime)
Number of subjects: 544

Group type: COMPARATOR
Intervention: No prophylactic antibiotics
Number of subjects: 544
Study: 1975490

Group type: EXPERIMENTAL
Intervention: Patient-controlled analgesia (PCA) with morphine sulfate
Number of subjects: 83

Group type: COMPARATOR
Intervention: Intramuscular morphine injections as needed
Number of subjects: 83
Study: 7150

Group type: EXPERIMENTAL
Intervention: Gallamine triethiodide (40 mg)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Control group (no muscle relaxant)
Number of subjects: 20
Study: 31869726

Group type: EXPERIMENTAL
Intervention: G1: 24 sets of five repetitions with 30 s rest at 80% of one repetition maximum using Iowa Oral Performance Instrument (IOPI) per day
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: G2: Forceful swallow of 5 mL of water in a neutral posture every 10 s for 20 min per day
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: G3: 5 mL of water swallowing exercise in chin-down posture every 10 s for 20 min per day
Number of subjects: 31
Study: 30710323

Group type: EXPERIMENTAL
Intervention: Definitive radiochemotherapy (RCT)
Number of subjects: 169
Study: 26313129

Group type: EXPERIMENTAL
Intervention: Cognitive intervention
Number of subjects: 0
Study: 26075813

Group type: EXPERIMENTAL
Intervention: MenACWY-CRM
Number of subjects: 93

Group type: EXPERIMENTAL
Intervention: MenACWY-TT
Number of subjects: 93
Study: 23216622

Group type: EXPERIMENTAL
Intervention: Tacrolimus
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Intravenous immunoglobulins (IVIG)
Number of subjects: 21

Group type: COMPARATOR
Intervention: Historical control (untreated patients)
Number of subjects: 21
Study: 21778216

Group type: EXPERIMENTAL
Intervention: Caloric restriction (CR) for 6 months
Number of subjects: 48
Study: 19335744

Group type: EXPERIMENTAL
Intervention: Sitaxsentan
Number of subjects: 229

Group type: COMPARATOR
Intervention: Bosentan
Number of subjects: 229
Study: 17891897

Group type: EXPERIMENTAL
Intervention: Caffeine (CAF) 200 mg administered at specified times during Days 2-4
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Caffeine (CAF) 200 mg
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo (PLAC)
Number of subjects: 20
Study: 14718884

Group type: EXPERIMENTAL
Intervention: Test tooth (maxillary first premolar subjected to orthodontic force)
Number of subjects: 17

Group type: COMPARATOR
Intervention: Control tooth (contralateral first premolar not subjected to mechanical stress)
Number of subjects: 17
Study: 11161370

Group type: EXPERIMENTAL
Intervention: DepoCyte 50 mg injected once every 2 weeks for one month of induction therapy
Number of subjects: 43

Group type: EXPERIMENTAL
Intervention: DepoCyte 50 mg
Number of subjects: 43
Study: 9002389

Group type: EXPERIMENTAL
Intervention: White light treatment for 2 weeks
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo red light treatment for 2 weeks
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Summer performance assessment
Number of subjects: 30
Study: 7989947

Group type: EXPERIMENTAL
Intervention: Limb-salvage surgery
Number of subjects: 348

Group type: EXPERIMENTAL
Intervention: Wide amputations
Number of subjects: 348

Group type: COMPARATOR
Intervention: Radical amputation
Number of subjects: 348

Group type: COMPARATOR
Intervention: Rotationplasty
Number of subjects: 348

Group type: EXPERIMENTAL
Intervention: Chemotherapy response
Number of subjects: 348

Group type: EXPERIMENTAL
Intervention: Surgical margins
Number of subjects: 348

Group type: EXPERIMENTAL
Intervention: Age
Number of subjects: 348
Study: 2464104

Group type: EXPERIMENTAL
Intervention: Bisoprolol (20 mg)
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Atenolol (100 mg)
Number of subjects: 8

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 8
Study: 28544687

Group type: EXPERIMENTAL
Intervention: Quadriceps isometric contraction exercise
Number of subjects: 250

Group type: COMPARATOR
Intervention: Local physiotherapy and oral nonsteroidal anti‐inflammatory drugs
Number of subjects: 250
Study: 27869712

Group type: EXPERIMENTAL
Intervention: Pterocarpan-high soybean leaf extract (PT) 2 g/day for 12 weeks
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo (starch, 3 g/day) for 12 weeks
Number of subjects: 0
Study: 24964508

Group type: EXPERIMENTAL
Intervention: Multiple myeloma (MM) patients
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Multiple myeloma IgG group
Number of subjects: 21

Group type: COMPARATOR
Intervention: Healthy volunteers (controls)
Number of subjects: 21
Study: 22514205

Group type: EXPERIMENTAL
Intervention: FES-cycling
Number of subjects: 35

Group type: COMPARATOR
Intervention: Placebo FES-cycling
Number of subjects: 35
Study: 20679774

Group type: EXPERIMENTAL
Intervention: L-BIS group (BIS values 20-30)
Number of subjects: 70

Group type: COMPARATOR
Intervention: H-BIS group (BIS values 50-60)
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: L-BIS group
Number of subjects: 70

Group type: COMPARATOR
Intervention: H-BIS group
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 70
Study: 18423987

Group type: EXPERIMENTAL
Intervention: Aripiprazole
Number of subjects: 555

Group type: COMPARATOR
Intervention: Standard of Care (SOC)
Number of subjects: 555
Study: 16052084

Group type: EXPERIMENTAL
Intervention: Single-dose nevirapine (NVP)
Number of subjects: 1051

Group type: COMPARATOR
Intervention: 6 weeks of zidovudine (ZDV)
Number of subjects: 1051

Group type: COMPARATOR
Intervention: NVP and ZDV (comparison)
Number of subjects: 1051

Group type: COMPARATOR
Intervention: ZDV use
Number of subjects: 1051

Group type: COMPARATOR
Intervention: Maternal CD4 cell count < 500 x 10(6) cells/l
Number of subjects: 1051

Group type: COMPARATOR
Intervention: Maternal viral load > 50 000 copies/ml
Number of subjects: 1051

Group type: COMPARATOR
Intervention: Breastfeeding
Number of subjects: 1051
Study: 11840370

Group type: EXPERIMENTAL
Intervention: Capillary blood glucose (BG) measurements
Number of subjects: 23
Study: 10460925

Group type: EXPERIMENTAL
Intervention: Parapertussis
Number of subjects: 81

Group type: EXPERIMENTAL
Intervention: Pertussis
Number of subjects: 81
Study: 7488480

Group type: EXPERIMENTAL
Intervention: 100% oxygen
Number of subjects: 51

Group type: EXPERIMENTAL
Intervention: 70% nitrous oxide in oxygen
Number of subjects: 51

Group type: EXPERIMENTAL
Intervention: 30% oxygen in nitrogen
Number of subjects: 51
Study: 2021986

Group type: EXPERIMENTAL
Intervention: Epidural nalbuphine (0.075-0.3 mg.kg-1)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Epidural morphine (0.1 mg.kg-1)
Number of subjects: 0
Study: 6177846

Group type: EXPERIMENTAL
Intervention: Naldecon (antihistamine-decongestant)
Number of subjects: 53

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 53
Study: 30231750

Group type: EXPERIMENTAL
Intervention: Mobile priming with attachment security visualization tasks over a 7-day period
Number of subjects: 112

Group type: EXPERIMENTAL
Intervention: Participants who reported less effort and more pleasure in visualization tasks
Number of subjects: 112
Study: 30120446

Group type: EXPERIMENTAL
Intervention: Hard first intervention (less frequent, atelic, phonologically complex verbs)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Easy first intervention (highly frequent, telic, phonologically simple verbs)
Number of subjects: 20
Study: 26735993

Group type: EXPERIMENTAL
Intervention: ATG
Number of subjects: 168

Group type: COMPARATOR
Intervention: Non-ATG
Number of subjects: 168
Study: 25233654

Group type: EXPERIMENTAL
Intervention: Fire needling therapy
Number of subjects: 60

Group type: COMPARATOR
Intervention: Oxycycline tablets (100 mg, twice daily for 20 days) with external application of adapalene gel before sleep
Number of subjects: 60

Group type: COMPARATOR
Intervention: Oxycycline tablets
Number of subjects: 60
Study: 22608570

Group type: EXPERIMENTAL
Intervention: Oral corticosteroids (OCSs), more than 2 courses per year
Number of subjects: 780

Group type: COMPARATOR
Intervention: Oral corticosteroids (OCSs), less than or equal to 2 courses per year
Number of subjects: 780

Group type: EXPERIMENTAL
Intervention: Oral corticosteroids (OCSs)
Number of subjects: 780
Study: 20807066

Group type: EXPERIMENTAL
Intervention: Single-dose, immediate-release dexmethylphenidate (dMPH)
Number of subjects: 10

Group type: COMPARATOR
Intervention: No medication
Number of subjects: 10
Study: 17925654

Group type: EXPERIMENTAL
Intervention: Every 3 day catheter exchange (q3day)
Number of subjects: 196

Group type: COMPARATOR
Intervention: Every 4 day catheter exchange (q4day)
Number of subjects: 196
Study: 16722590

Group type: EXPERIMENTAL
Intervention: Radial artery (RA) grafts
Number of subjects: 52

Group type: COMPARATOR
Intervention: Long saphenous vein (LSV) grafts
Number of subjects: 52
Study: 12637133

Group type: EXPERIMENTAL
Intervention: Pharmacokinetic dosing (n=43)
Number of subjects: 81

Group type: COMPARATOR
Intervention: Fixed once‐daily dosing (n=38)
Number of subjects: 81
Study: 10982163

Group type: EXPERIMENTAL
Intervention: Calcium carbonate supplement alone (750 mg daily)
Number of subjects: 53

Group type: EXPERIMENTAL
Intervention: Calcium carbonate plus calcitriol (750 mg calcium carbonate + 0.5 microg calcitriol daily)
Number of subjects: 53

Group type: COMPARATOR
Intervention: Both interventions (calcium alone and calcium plus calcitriol)
Number of subjects: 53
Study: 9208534

Group type: EXPERIMENTAL
Intervention: Shengmaisan (SMS)
Number of subjects: 62

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 62
Study: 1480877

Group type: EXPERIMENTAL
Intervention: Test drug given once daily
Number of subjects: 35

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 35
Study: 6198064

Group type: EXPERIMENTAL
Intervention: High-dose cisplatin (120 mg/m2, monthly) combined with vinblastine and bleomycin
Number of subjects: 114

Group type: COMPARATOR
Intervention: Low-dose cisplatin (15 mg/m2, daily X 5 monthly) combined with vinblastine and bleomycin
Number of subjects: 114
Study: 30994898

Group type: EXPERIMENTAL
Intervention: Quality of Care Improvement (QCI) intervention
Number of subjects: 29346

Group type: COMPARATOR
Intervention: Usual care (control)
Number of subjects: 29346
Study: 29432613

Group type: EXPERIMENTAL
Intervention: Baseline TRAIL
Number of subjects: 103

Group type: EXPERIMENTAL
Intervention: Baseline Dkk1
Number of subjects: 103

Group type: EXPERIMENTAL
Intervention: Baseline CTX-1
Number of subjects: 103
Study: 27427235

Group type: EXPERIMENTAL
Intervention: 0.625 mg conjugated equine estrogens (CEE) daily for 28 days
Number of subjects: 64

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 64
Study: 24529546

Group type: EXPERIMENTAL
Intervention: VALOR II
Number of subjects: 223

Group type: COMPARATOR
Intervention: VALOR
Number of subjects: 223

Group type: EXPERIMENTAL
Intervention: VALOR test arm
Number of subjects: 223
Study: 22327404

Group type: EXPERIMENTAL
Intervention: Lipid/heparin emulsion (Intralipid) infusion
Number of subjects: 10

Group type: COMPARATOR
Intervention: Saline infusion
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Heparin only infusion
Number of subjects: 10
Study: 20192907

Group type: EXPERIMENTAL
Intervention: t'ai chi program
Number of subjects: 82

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 82
Study: 17326908

Group type: EXPERIMENTAL
Intervention: ProSeal laryngeal mask airway (PLMA)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Standard laryngeal mask airway (SLMA)
Number of subjects: 50
Study: 16139778

Group type: EXPERIMENTAL
Intervention: Individually tailored behavioral medicine intervention
Number of subjects: 122

Group type: COMPARATOR
Intervention: Physical exercise therapy
Number of subjects: 122
Study: 11966744

Group type: EXPERIMENTAL
Intervention: 75 IU recFSH
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: 150 IU recFSH
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: 225 IU recFSH
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: 150 IU uFSH
Number of subjects: 36

Group type: COMPARATOR
Intervention: Lyndiol (2.5 mg lynestrenol + 0.05 mg ethinyl‐oestradiol)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Pill-free period
Number of subjects: 36

Group type: COMPARATOR
Intervention: Lyndiol
Number of subjects: 36
Study: 10409137

Group type: EXPERIMENTAL
Intervention: Progressive resistance training and multinutrient supplementation
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: Progressive resistance training
Number of subjects: 26
Study: 7558212

Group type: EXPERIMENTAL
Intervention: Intraumbilical oxytocin (10 units in 20 ml saline)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Control group (oxytocin infusion 10 units in 250 ml of dextrose saline at 125 ml/hr)
Number of subjects: 100
Study: 2288128

Group type: EXPERIMENTAL
Intervention: Surgery combined with preoperative Co 60 gamma teletherapy (139 cases)
Number of subjects: 281

Group type: COMPARATOR
Intervention: Surgery alone (142 cases)
Number of subjects: 281

Group type: EXPERIMENTAL
Intervention: Preoperative Co 60 gamma teletherapy (part of combined treatment)
Number of subjects: 281
Study: 6789851

Group type: EXPERIMENTAL
Intervention: Sodium cromoglycate dry powder inhalation (20 mg/dose)
Number of subjects: 29

Group type: COMPARATOR
Intervention: Metered dose aerosol (2 mg/dose)
Number of subjects: 29
Study: 30721793

Group type: EXPERIMENTAL
Intervention: Cyclin D1 overexpression
Number of subjects: 54
Study: 28714728

Group type: EXPERIMENTAL
Intervention: Cognitive-behavioral therapy (CBT) plus contingency management (CM)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Cognitive-behavioral therapy (CBT) plus no CM
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Disulfiram
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 25856757

Group type: EXPERIMENTAL
Intervention: THA physiotherapy care protocol (THAPCP)
Number of subjects: 106

Group type: COMPARATOR
Intervention: THA protocol (THAP)
Number of subjects: 106
Study: 23267373

Group type: EXPERIMENTAL
Intervention: Surgical intervention (turbinoplasty with functional endoscopic sinus surgery)
Number of subjects: 44

Group type: COMPARATOR
Intervention: Medical intervention (fluticason nasal spray and oral Pseudoephedrin)
Number of subjects: 44
Study: 19200398

Group type: EXPERIMENTAL
Intervention: D-Ribose
Number of subjects: 26

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 26
Study: 17403076

Group type: EXPERIMENTAL
Intervention: Rabeprazole 20 mg (PPI group)
Number of subjects: 143

Group type: COMPARATOR
Intervention: Cimetidine 800 mg (H2RA group)
Number of subjects: 143
Study: 15110132

Group type: EXPERIMENTAL
Intervention: Rofecoxib (25 mg) once daily for 7 days
Number of subjects: 62

Group type: COMPARATOR
Intervention: Diclofenac (75 mg) once daily for 7 days
Number of subjects: 62

Group type: COMPARATOR
Intervention: Meloxicam (7.5 mg) once daily for 7 days
Number of subjects: 62

Group type: EXPERIMENTAL
Intervention: All regimens
Number of subjects: 62
Study: 11673199

Group type: EXPERIMENTAL
Intervention: 100 micron/d of HFA-134a beclomethasone dipropionate
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: 800 micron/d of HFA-134a beclomethasone dipropionate
Number of subjects: 12
Study: 9855324

Group type: EXPERIMENTAL
Intervention: Levofloxacin 500 mg once/day for 14 days
Number of subjects: 216

Group type: COMPARATOR
Intervention: Clarithromycin 500 mg twice/day for 14 days
Number of subjects: 216
Study: 8050421

Group type: EXPERIMENTAL
Intervention: General anaesthesia
Number of subjects: 14

Group type: COMPARATOR
Intervention: Lumbar epidural anaesthesia
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Surgery
Number of subjects: 14
Study: 3184885

Group type: EXPERIMENTAL
Intervention: Marijuana-laced brownies (1.6 g of marijuana plant material, 2.8% THC)
Number of subjects: 5

Group type: COMPARATOR
Intervention: Placebo brownies (0% THC)
Number of subjects: 5
Study: 30287202

Group type: EXPERIMENTAL
Intervention: Platelet-rich fibrin (PRF) applied to extraction sockets (group A)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control group (group B) - sockets closed without PRF
Number of subjects: 30
Study: 28588109

Group type: EXPERIMENTAL
Intervention: Arthroscopic subacromial decompression (ASD)
Number of subjects: 210

Group type: COMPARATOR
Intervention: Diagnostic arthroscopy (DA)
Number of subjects: 210

Group type: COMPARATOR
Intervention: Supervised progressive exercise therapy (ET)
Number of subjects: 210

Group type: EXPERIMENTAL
Intervention: ASD, DA, ET
Number of subjects: 210
Study: 25205534

Group type: EXPERIMENTAL
Intervention: Very low-dose INR self-control (VLO group)
Number of subjects: 1571

Group type: EXPERIMENTAL
Intervention: Very low-dose INR self-control (VLT group)
Number of subjects: 1571

Group type: COMPARATOR
Intervention: Low-dose INR self-control (LOW group)
Number of subjects: 1571
Study: 23810482

Group type: EXPERIMENTAL
Intervention: Men
Number of subjects: 33345

Group type: COMPARATOR
Intervention: Women
Number of subjects: 33345

Group type: EXPERIMENTAL
Intervention: Older patients (age > 65 years)
Number of subjects: 33345

Group type: EXPERIMENTAL
Intervention: Overall cohort
Number of subjects: 33345
Study: 20807260

Group type: EXPERIMENTAL
Intervention: Dill extract (1%)
Number of subjects: 0
Study: 19285585

Group type: EXPERIMENTAL
Intervention: Participatory ergonomics process
Number of subjects: 0
Study: 17023847

Group type: EXPERIMENTAL
Intervention: Microdiscectomy
Number of subjects: 56

Group type: COMPARATOR
Intervention: Conservative management
Number of subjects: 56

Group type: EXPERIMENTAL
Intervention: Microdiscectomy (for L4-L5 herniation)
Number of subjects: 56
Study: 12781108

Group type: EXPERIMENTAL
Intervention: Nicotine dependence assessment using the modified Fagerström Test for Nicotine Dependence (FTND)
Number of subjects: 2647

Group type: COMPARATOR
Intervention: Not applicable
Number of subjects: 2647
Study: 15570231

Group type: EXPERIMENTAL
Intervention: 0.25% bupivacaine infusion at a rate of 6 mL/h
Number of subjects: 50

Group type: COMPARATOR
Intervention: Saline solution
Number of subjects: 50
Study: 10406050

Group type: EXPERIMENTAL
Intervention: Infants with IALTE
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Mothers of infants with IALTE
Number of subjects: 19

Group type: COMPARATOR
Intervention: Mothers of control infants
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Correlation of perceived 'difficultness' in infants with IALTE
Number of subjects: 19
Study: 7494801

Group type: EXPERIMENTAL
Intervention: CR tablet A (acetaminophen A)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: CR tablet B (acetaminophen B)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Both CR tablets A and B
Number of subjects: 0
Study: 2399001

Group type: EXPERIMENTAL
Intervention: Honan intraocular pressure (IOP) reducer
Number of subjects: 30

Group type: COMPARATOR
Intervention: Digital pressure
Number of subjects: 30
Study: 748569

Group type: EXPERIMENTAL
Intervention: Rifampicin
Number of subjects: 71

Group type: COMPARATOR
Intervention: Ethambutol
Number of subjects: 71
Study: 31955525

Group type: EXPERIMENTAL
Intervention: Anti-EGFR antibody plus chemotherapy
Number of subjects: 203
Study: 31290518

Group type: EXPERIMENTAL
Intervention: SCF‐B (biscuits supplemented with antioxidant dietary fiber isolated from spent coffee grounds)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: SC‐FOS‐B (combination of spent coffee grounds and fructooligosaccharides)
Number of subjects: 0

Group type: COMPARATOR
Intervention: TB (traditional recipe without added fiber)
Number of subjects: 0
Study: 28759967

Group type: EXPERIMENTAL
Intervention: Motor learning exercise program on compensatory STS maneuvers (n = 51)
Number of subjects: 97

Group type: COMPARATOR
Intervention: Low‐intensity motor placebo activity (n = 46)
Number of subjects: 97

Group type: EXPERIMENTAL
Intervention: Motor learning exercise program on compensatory STS maneuvers
Number of subjects: 97
Study: 25820243

Group type: EXPERIMENTAL
Intervention: CPAP
Number of subjects: 38

Group type: COMPARATOR
Intervention: Sham CPAP
Number of subjects: 38